NextCure, Inc.NXTCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank32
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P32
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-9.08%
Q3 202567.22%
Q2 2025-134.83%
Q1 20256.69%
Q4 20240.32%
Q3 202424.25%
Q2 20249.89%
Q1 2024-15.92%
Q4 2023-1.10%
Q3 202318.48%
Q2 2023-12.23%
Q1 20233.94%
Q4 20227.63%
Q3 2022-6.13%
Q2 202212.72%
Q1 2022-21.67%
Q4 20217.76%
Q3 2021-3.10%
Q2 2021-4.17%
Q1 2021-6.14%
Q4 20206.68%
Q3 2020-10.11%
Q2 2020-292.41%
Q1 2020168.38%
Q4 2019-23.79%
Q3 2019-8.34%
Q2 2019-31.40%
Q1 20193.57%
Q4 2018-21.43%
Q3 2018-9.81%
Q2 2018-5.81%
Q1 20180.00%